|
|
|
|
|
|
Regulus Therapeutics (RGLS)
|
|
1.32 +0.04 (+3.13%)
|
10/17/2017 4:00pm
|
|
Open:
|
1.30
|
Pre. Close:
|
1.28
|
|
High:
|
1.35
|
Low:
|
1.24
|
|
Volume:
|
323,711
|
Market Cap:
|
137.00M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
1.37 - 1.4
|
1.4 - 1.44
|
|
Low:
|
1.18 - 1.19
|
1.19 - 1.22
|
|
Close:
|
1.28 - 1.32
|
1.32 - 1.38
|
|
|
|
|
|
|
Technical analysis (as of: 2017-10-17 4:42:18 PM)
|
|
Overall:
|
 
|
|
Stoxline posted a NEUTRAL today, upgraded from lower rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.
|
|
Target:
|
Six months: 1.78 One year: 2.07
|
|
Support:
|
Support1: 1.26 Support2: 1.10
|
|
Resistance:
|
Resistance1:
1.52 Resistance2: 1.78
|
|
Pivot:
|
1.34 
|
|
Moving Averages:
|
MA(5): 1.31 MA(20): 1.34
MA(100): 1.12 MA(250): 1.59
|
|
MACD:
|
MACD(12,26):
0.04 Signal(12,26,9): 0.06
|
|
%K %D:
|
%K(14,3): 32.24 %D(3): 32.36
|
|
RSI:
|
RSI(14): 54.06
|
|
52-Week:
|
High: 3.38
Low: 0.79 Change(%): -50.9
|
|
Average Vol(K):
|
3-Month: 79429
10-Days 45527
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.RGLS has closed above bottom band by 41.4%. Bollinger Bands are 40.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to RGLS's normal range. The bands have been in this narrow range for 9 bars. This is a sign that the market may be about to initiate a new trend.
|
|
|
Headline News
|
|
Fri, 13 Oct 2017 21:30:06 GMT
Regulus Therapeutics Inc. (RGLS) Plunges 6.02% on October 13
Mon, 02 Oct 2017 21:30:05 GMT
Regulus Therapeutics Inc. (RGLS) Moves Higher on Volume Spike for October 02
Tue, 17 Oct 2017 12:22:30 GMT
Marching to the Beat of Their Own Drum, Update on Regulus Therapeutics Inc.
Mon, 12 Jun 2017 10:52:30 GMT
Regulus Announces Pipeline Updates and Advancements
Sun, 07 May 2017 15:33:45 GMT
Regulus Therapeutics' (RGLS) CEO Paul Grint on Q1 2017 Results - Earnings Call ...
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
